Drug screening for Parkinson's Disease (PD) often involves testing compounds for their potential to modulate key cellular processes associated with the disease. Calcium signaling and β-arrestin mobilization are two important cellular events that can be targeted in drug discovery efforts for PD. Calcium signaling plays a critical role in neuronal function and is disrupted in neurodegenerative diseases like PD. β-arrestins are proteins that play a role in regulating G-protein coupled receptor (GPCR) signaling, which is implicated in various cellular processes including dopaminergic signaling.
By targeting calcium signaling and β-arrestin mobilization, Creative Bioarray aims to identify compounds that can modulate key cellular processes associated with PD, potentially leading to the development of novel therapeutic interventions for the disease.
Online Inquiry
